17-30318899-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000328886.5(TMIGD1):c.655G>T(p.Val219Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000657 in 152,154 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000328886.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMIGD1 | NM_206832.3 | c.655G>T | p.Val219Leu | missense_variant | 5/7 | ENST00000328886.5 | NP_996663.1 | |
TMIGD1 | XM_011524787.2 | c.655G>T | p.Val219Leu | missense_variant | 5/7 | XP_011523089.1 | ||
TMIGD1 | NM_001319942.2 | c.641-1666G>T | intron_variant | NP_001306871.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMIGD1 | ENST00000328886.5 | c.655G>T | p.Val219Leu | missense_variant | 5/7 | 1 | NM_206832.3 | ENSP00000332404.4 | ||
TMIGD1 | ENST00000538566.6 | c.641-1666G>T | intron_variant | 2 | ENSP00000446118.2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152154Hom.: 0 Cov.: 31
GnomAD4 exome Cov.: 29
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152154Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74328
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2024 | The c.655G>T (p.V219L) alteration is located in exon 5 (coding exon 4) of the TMIGD1 gene. This alteration results from a G to T substitution at nucleotide position 655, causing the valine (V) at amino acid position 219 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at